Dianthus Therapeutics Stock Technical Analysis

DNTH Stock   23.83  0.03  0.13%   
As of the 29th of November, Dianthus Therapeutics shows the Standard Deviation of 3.83, coefficient of variation of (1,863), and Mean Deviation of 2.81. Dianthus Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Dianthus Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Dianthus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Dianthus
  
Dianthus Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Dianthus Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
24.0Strong Buy11Odds
Dianthus Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Dianthus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Dianthus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Dianthus Therapeutics, talking to its executives and customers, or listening to Dianthus conference calls.
Dianthus Analyst Advice Details
Dianthus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Dianthus Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Dianthus Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Dianthus Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Dianthus Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Dianthus Therapeutics Trend Analysis

Use this graph to draw trend lines for Dianthus Therapeutics. You can use it to identify possible trend reversals for Dianthus Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Dianthus Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Dianthus Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Dianthus Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.06  , which may suggest that Dianthus Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 119.79, which is the sum of squared deviations for the predicted Dianthus Therapeutics price change compared to its average price change.

About Dianthus Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Dianthus Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Dianthus Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Dianthus Therapeutics price pattern first instead of the macroeconomic environment surrounding Dianthus Therapeutics. By analyzing Dianthus Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Dianthus Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Dianthus Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2022 2023 (projected)
Payables Turnover0.130.14
Days Of Inventory On Hand2.1K1.9K

Dianthus Therapeutics November 29, 2024 Technical Indicators

Most technical analysis of Dianthus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Dianthus from various momentum indicators to cycle indicators. When you analyze Dianthus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Complementary Tools for Dianthus Stock analysis

When running Dianthus Therapeutics' price analysis, check to measure Dianthus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dianthus Therapeutics is operating at the current time. Most of Dianthus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dianthus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dianthus Therapeutics' price. Additionally, you may evaluate how the addition of Dianthus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Correlations
Find global opportunities by holding instruments from different markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Money Managers
Screen money managers from public funds and ETFs managed around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated